GlassScriptPhysician profile
Ibrahim Tsolakian
NPI 1194380428
$865.33
in general payments reported to CMS, 2019-2025
17 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $89.97 · 2024: $386 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $210.18 | 2024-2025 | Veozah |
| Axonics, INC. | $99.54 | 2024 | Axonics |
| Intuitive Surgical, INC. | $85.59 | 2025 | |
| Myriad Women'S Health, INC. | $72.03 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $59.06 | 2024-2025 | Aptima, Novasure, Omni Hysteroscope |
| Organon LLC | $56.91 | 2024-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $44.81 | 2024-2025 | Gemtesa |
| Sage Therapeutics, LLC | $42.73 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $35.07 | 2023-2024 | |
| Abbvie INC. | $26.64 | 2025 | |
| Coopersurgical, INC. | $23.62 | 2024 | Paragard T 380a |
| Evofem Biosciences, INC. | $22.56 | 2025 | Phexxi, Solosec, Phexx |
| Vertex Pharmaceuticals Incorporated | $19.80 | 2024 | |
| Molnlycke Health Care US, LLC | $18.59 | 2025 | Biogel Pi Ultratouch, Biogel Pi Micro Indicator Underglove, Biogel Indicator System |
| Ethicon US, LLC | $17.90 | 2024 | Harmonic, Stratafix, Ethicon |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $15.37 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Tsolakian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.